<DOC>
	<DOCNO>NCT01349036</DOCNO>
	<brief_summary>The objective study evaluate response subject recurrent glioblastoma continuous therapy PLX3397 .</brief_summary>
	<brief_title>A Phase 2 Study PLX3397 Patients With Recurrent Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Male female patient ≥18 year old life expectancy least 8 week Radiographically proven recurrent ( ≥ first relapse ) , intracranial GBM For patient , availability least 10 unstained slide ( archival tumor block sufficient generate least 10 unstained slide ) previous GBM surgery Previous treatment external beam radiation temozolomide chemotherapy Before first dose PLX3397 , adequate recovery toxicity prior therapy follow : &gt; 28 day cytotoxic therapy &gt; 42 day nitrosoureas &gt; 28 day bevacizumab &gt; 7 day non cytotoxic therapy interferon , tamoxifen , thalidomide , cisretinoic acid , erlotinib Women childbearing potential must negative pregnancy test within 7 day initiation dosing must agree use acceptable method birth control study drug 3 month last dose . Women nonchildbearing potential may include either surgically sterile postmenopausal ≥1 year . Men childbearing potential must also agree use acceptable method birth control study drug . Karnofsky performance status ≥60 Adequate hematologic , hepatic , renal function ( absolute neutrophil count ≥1.0 x 109/L , Hgb &gt; 9 g/dL , platelet count ≥50 x 109/L , AST/ALT ≤2.5x ULN , creatinine ≤1.5x ULN ) Willing able provide write informed consent prior study related procedure comply study requirement Investigational drug use within 28 day first dose PLX3397 GBM progression within 3 month previous radiation RANO criterion History Grade 2 ( CTCAE v4 ) great acute intracranial hemorrhage Previous failure bevacizumab VEGF therapy except first line set History malignant glioma codeletion 1p/19q A concurrent active cancer require nonsurgical therapy ( e.g . chemotherapy , radiation , adjuvant therapy ) . Prior history cancer allow , long active disease within prior 3 year . Refractory nausea vomiting , malabsorption , biliary shunt , significant bowel resection would preclude adequate absorption Patients serious illness , uncontrolled infection , medical condition , medical history include abnormal laboratory result , investigator 's opinion would likely interfere patient 's participation study , interpretation result Women childbearing potential pregnant breast feeding QTc ≥450 msec Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>GBM</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>brain cancer</keyword>
</DOC>